Welcome to our dedicated page for Gcp Applied Technologies news (Ticker: GCP), a resource for investors and traders seeking the latest updates and insights on Gcp Applied Technologies stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Gcp Applied Technologies's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Gcp Applied Technologies's position in the market.
GCP Applied Technologies reported 1Q20 results, featuring a 4.2% decline in net sales year-over-year to $216.7 million, impacted by lower sales volumes and currency translation. Adjusted EBITDA rose 17.6% to $26.0 million, while Adjusted EPS grew 42.9% to $0.10. Income from continuing operations attributable to GCP shareholders significantly dropped to $1.4 million, a 90.4% decrease. The company maintains a strong balance sheet with $320.2 million in cash and $670 million in liquidity, positioning it to navigate challenges during the COVID-19 pandemic.
Summary not available.
Summary not available.